Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Keeney

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Cancer Research|September 1, 1981
Comments on the effects of dietary trans-fatty acids in humansM Keeney
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|March 1, 1996
ADA compliance--easy steps, vast rewardsE M Keeney
American Pharmacy|October 1, 1995
Alaskan adventures in pharmacyE M Keeney
International Journal of Laboratory Hematology|April 18, 2013
Technical issues: flow cytometry and rare event analysisB D Hedley, M Keeney
Cytotherapy|June 5, 2002
Stem cell enumeration by flow cytometry: current concepts and recent developments in CD34+ cell enumerationM Keeney, D R Sutherland
Thrombosis and Haemostasis|August 6, 2000
Inter-assay and instrument variability of anti-Xa--resultsM J Kovacs, M Keeney
Current Opinion in Microbiology|January 11, 2011
Enteric pathogen exploitation of the microbiota-generated nutrient environment of the gutKristie M Keeney, B Brett Finlay
Mitochondrion|June 5, 2020
Alzheimer's and Parkinson's brain tissues have reduced expression of genes for mtDNA OXPHOS Proteins, mitobiogenesis regulator PGC-1α protein and mtRNA stabilizing protein LRPPRC (LRP130)James P Bennett, Paula M Keeney
Acta Neuropathologica|January 1, 1986
Immunoenzymatic labelling of JC papovavirus T antigen in brains of patients with progressive multifocal leukoencephalopathyJ E Greenlee, P M Keeney
Journal of Alzheimer'S Disease Reports|November 28, 2018
RNA-Sequencing Reveals Similarities and Differences in Gene Expression in Vulnerable Brain Tissues of Alzheimer's and Parkinson's DiseasesJames P Bennett, Paula M Keeney
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Cancer Research|September 1, 1981
Comments on the effects of dietary trans-fatty acids in humansM Keeney
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|March 1, 1996
ADA compliance--easy steps, vast rewardsE M Keeney
American Pharmacy|October 1, 1995
Alaskan adventures in pharmacyE M Keeney
International Journal of Laboratory Hematology|April 18, 2013
Technical issues: flow cytometry and rare event analysisB D Hedley, M Keeney
Cytotherapy|June 5, 2002
Stem cell enumeration by flow cytometry: current concepts and recent developments in CD34+ cell enumerationM Keeney, D R Sutherland
Thrombosis and Haemostasis|August 6, 2000
Inter-assay and instrument variability of anti-Xa--resultsM J Kovacs, M Keeney
Current Opinion in Microbiology|January 11, 2011
Enteric pathogen exploitation of the microbiota-generated nutrient environment of the gutKristie M Keeney, B Brett Finlay
Mitochondrion|June 5, 2020
Alzheimer's and Parkinson's brain tissues have reduced expression of genes for mtDNA OXPHOS Proteins, mitobiogenesis regulator PGC-1α protein and mtRNA stabilizing protein LRPPRC (LRP130)James P Bennett, Paula M Keeney
Acta Neuropathologica|January 1, 1986
Immunoenzymatic labelling of JC papovavirus T antigen in brains of patients with progressive multifocal leukoencephalopathyJ E Greenlee, P M Keeney
Journal of Alzheimer'S Disease Reports|November 28, 2018
RNA-Sequencing Reveals Similarities and Differences in Gene Expression in Vulnerable Brain Tissues of Alzheimer's and Parkinson's DiseasesJames P Bennett, Paula M Keeney
Pageof 12